Background Low-grade serous carcinoma of the ovary or peritoneum is characterised by
MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade …

Endometrioid ovarian carcinoma (EnOC) demonstrates substantial clinical and molecular
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …

Clear cell carcinoma of the ovary has distinct biology and clinical behavior. There are significant
geographical and racial differences in the incidence of clear cell carcinoma compared …

Epithelial ovarian cancer represents the most lethal gynecological malignancy in the
developed world, and can be divided into five main histological subtypes: high grade serous, …

The estrogen receptor (ER) has functionality in selected ovarian cancer subtypes and
represents a potential target for therapy. The majority (>80%) of high grade serous, low grade …

Ovarian carcinoma (OC) is an umbrella term for multiple distinct diseases (histotypes), each
with their own developmental origins, clinical behaviour and molecular profile. Accordingly, …

Background Ovarian carcinosarcoma (OCS) is an uncommon, biphasic and highly aggressive
ovarian cancer type, which has received relatively little research attention. Methods We …

Approximately a fifth of ovarian carcinoma (OC) is associated with inherited germline
mutations, most commonly in the DNA repair genes BRCA1 or BRCA2 (BRCA). BRCA1- and …

Purpose: The abundance and effects of structural variation at BRCA1/2 in tumors are not well
understood. In particular, the impact of these events on homologous recombination repair …

Background Approximately half of high‐grade serous ovarian carcinomas (HGSOCs) demonstrate
homologous recombination repair (HR) pathway defects, resulting in a distinct clinical …